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Objective: The outcomes of carotid angioplasty and stenting (CAS) are, in addition to patient baseline characteristics,
highly dependent on the safety of the endovascular procedure. During the successive stages of CAS, transcranial Doppler
(TCD)monitoring of themiddle cerebral artery was used to assess the association of cerebral embolism and hemodynamic
changes with transient (amaurosis fugax and transient ischemic attack) and persistent (minor and major stroke) cerebral
deficits, and death.
Methods: By use of a prospectively completed database of 550 patients, the association of various TCD emboli and velocity
variables with periprocedural cerebral outcome<7 days was evaluated by univariable andmultivariable logistic regression
analyses in combination with receiver operating characteristic (ROC) curve analyses. The impact of basic patient
characteristics, such as age, sex, preprocedural cerebral symptoms, and ipsilateral carotid endarterectomy before CAS was
also evaluated.
Results:We observed 36 patients with amaurosis fugax (n 6; 1.1%) or transient ischemic attack (n 30; 5.4%), 1 patient
(0.2%) with an ipsilateral retinal infarct, and 21 patients with minor (n  15; 2.7%) or major (n  6; 1.1%) stroke,
respectively. Five patients (0.9%) died. Multiple showers of microemboli (>5) at postdilation after stent deployment
(odds ratio [OR] 2.6, 95% confidence interval [CI], 1.3 to 5.1), particulate macroembolus (OR, 27.0; 95% CI, 4.5 to
157), and massive air embolism (OR, 51.4; 95% CI, 5.4 to 492), as well as angioplasty-induced asystole and prolonged
hypotension with a >70% reduction of middle cerebral artery blood flow velocities (OR, 6.4; 95% CI, 2.3 to 17.8) were
independently associated with cerebral deficits. The ROC area of this model was 0.72. Of the patient characteristics, only
preprocedural cerebral ischemia (OR, 5.0; 95% CI, 2.4 to 10.4) was associated with outcome. Adding this patient
characteristic to the model, the area under the ROC curve increased to 0.80.
Conclusions: In CAS, in addition to such obviously adverse events as particulate macroembolism and massive air
embolism, multiple microemboli (>5 showers) at postdilation after stent deployment and angioplasty-induced asystole
and hypotension with a significant reduction of middle cerebral artery blood flow velocities are associated with
periprocedural cerebral deficits. In combination with the presence of preprocedural cerebral symptoms, these four TCD
monitoring variables reasonably differentiate between patients with and without adverse cerebral outcome. TCD
monitoring provides insight into the pathogenesis of CAS related adverse cerebral events. ( J Vasc Surg 2005;41:
618-24.)Carotid endarterectomy (CEA) has been used to treat
atherosclerotic carotid bifurcation disease for 50 years.
Over this period of time, the surgical technique has under-
gone minor modifications and the indications for repair
have been refined. This operation has held up to the scru-
tiny of several large multicenter randomized trials,1-4 and
more CEAs are currently being performed than at any time
in the history of this operation.
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618In terms of both safety and efficacy, carotid artery
stenting (CAS) has emerged as a potential alternative to
CEA in the last few years. Potential advantages of CAS
over CEA include avoidance of neck wound complica-
tions and nerve injuries and an ability to treat surgically
inaccessible lesions such as high internal carotid artery
(ICA) stenoses. The main hazard of CAS is that athero-
sclerotic material dislodged during the procedure may
embolize to the cerebral circulation and result in cerebral
ischemia. Moreover, extensive manipulation in the vicin-
ity of the carotid sinus leads to an increased parasympa-
thetic discharge and a reduction of systematic arterial
smooth muscle tone that can result in hypotension and
bradycardia.
As a result of recent developments in transcranial
Doppler (TCD) monitoring, not only can blood flow ve-
locities in the middle cerebral artery (MCA) be monitored,
but microemboli can also be detected. For example, its role
of evaluating the impact of cerebral microemboli on brain
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and perioperative TCDmonitoring can be used to evaluate
the pathogenesis of stroke complicating CEA.7
We have previously reported our experience with TCD
monitoring and its usefulness with regard to emboli detec-
tion in CAS.8,9 However, these studies were primarily
designed to test the pattern of microembolic phenomena
during various stages of the endovascular procedure and to
verify whether the use of filtering emboli protection devices
resulted in a decrease of the cerebral embolic load.
In the present study, we analyzed in a multivariable
logistic regressionmodel which TCD-detected emboli vari-
ables were associated with the occurrence of operative
cerebral complications (transient and persistent) and death
7 days after the procedure. In that regression model, we
also included intraoperative velocity variables and some
baseline patient characteristics. Identification of predictors
of outcome in CAS can be useful in understanding the
pathophysiologic mechanisms of cerebral complications
and may help to stratify patients according to their risk of
periprocedural stroke.
METHODS
Patients. The methods of our study are described
elsewhere.7,8 In brief, data from all patients who underwent






TCD emboli and velocity variables
Isolated emboli at predilation
Isolated emboli at stent deployment
Isolated emboli at postdilation
Isolated emboli by use of protection device
Showers at predilation
Showers at stent deployment
Showers at postdilation
5 showers of emboli at postdilation 1





Afx and TIA 36 (6.5%)
Retinal infarct 1 (0.2%)
Minor stroke 15 (2.7%)
Major stroke 6 (1.1%)
Death 5 (0.9%)
CEA, carotid endarterectomy; Afx, amaurosis fugax; TIA, transient ischem
Values of TCD microemboli variables (isolated and showers) are mean, m
percentages.
*Mean  SDCAS of the carotid bifurcation in our institution fromDecember 1997 through April 2004 were analyzed and
include 550 consecutive patients. Data were prospectively
entered into a database. Patients were excluded from CAS
in case of peripheral vascular or aortic arch disease suffi-
ciently severe to prevent adequate vascular access, severe
renal insufficiency, and severe disability due to previous
stroke or dementia. Patients who underwent angioplasty
with stent placement at the origin of the common carotid
artery were excluded from the present analysis. In patients
who underwent a second procedure (ipsilaterally or con-
tralaterally), only the first was included in the analysis,
leaving 550 analyzable procedures.
The risks and benefits of CAS compared with CEAwere
reviewed in detail with each patient before proceeding with
CAS, and this review was approved by the institutional
review board. The endovascular procedures were done by
interventional cardiologists or radiologists, respectively.
Most patients (361, 66%) were neurologically asymp-
tomatic, 189 patients (34%) had retinal or cerebral symp-
toms of amaurosis fugax (Afx), transient ischemic attack
(TIA), or minor stroke before treatment. In 385 patients
(70%), CAS was performed before coronary artery bypass
grafting, valve replacement, or reconstructive aortic sur-
gery. These and other baseline characteristics such as age,




































edianAccording to the North American Symptomatic Carotid
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April 2005620 Ackerstaff et alEndarterectomy Trial (NASCET) criteria,2 symptomatic
patients had a stenosis at the carotid bifurcation of 70%
and asymptomatic patients of80%. The degree of stenosis
was assessed by duplex ultrasound scanning and intra-
arterial digital subtraction angiography before the endovas-
cular procedure.
Carotid angioplasty and stenting. All patients took
aspirin (100 mg/d) and clopidogrel (75 mg/d) starting 3
days before the procedure. An intravenous bolus of 5,000
to 10,000 units of heparin was administered before sheath
insertion; 0.5 to 1.0 mg of atropine was administered
intravenously before predilation, poststent dilation, or
both, to prevent bradycardia during balloon inflation. Pa-
tients were treated under local anesthesia from a femoral
approach. If necessary, a predilation was performed with a
2.5- to 3.5-mm balloon, followed by introduction of a
self-expandable stent. Postdilation after stent deployment
was performed with a balloon size between 5 and 8 mm,
depending on the diameter of the ICA as determined by
preprocedural duplex scanning and intra-arterial digital
subtraction angiography.
A filtering cerebral emboli protection device was used
in 181 procedures (33%): the FilterWire (Boston Scientific,
Natick, Mass) was used in 130 patients, the AngioGuard
(Cordis, Minneapolis, Minn) in 27, and a variety of filters
were used in the remaining 24 patients. The use of a filter
wire protection device was at the discretion of the interven-
tionist and selected by availability. Balloon protection was
not evaluated in this study. Lesionmorphology and severity
of stenosis on screening duplex scans and diagnostic arte-
riograms were not used as selection criteria for embolic
protection. The filter was introduced before stent place-
ment, and whenever possible, before predilation. It was
either removed after postdilation or postprocedural arte-
riography.
Transcranial Doppler monitoring. The methods of
TCD monitoring during CAS have been described else-
where.8 In addition to hemodynamic changes during bal-
loon inflation at predilation and postdilation, the present
study had a special interest in the occurrence of isolated
microemboli according to the criteria described by the
consensus committee.10 The embolic signals that particu-
larly occur during balloon deflation and stent deployment
could not be counted individually, so the number of heart
beats with showers of microemboli were counted. A mac-
roembolus was defined as an embolus that partially or
completely obstructed the MCA main stem for a period of
several seconds to minutes.11
The Doppler spectra were observed in the angiography
suite by an experienced sonographer, and the audio Dopp-
ler signal was made audible throughout the entire proce-
dure. Moreover, for off-line analysis, the Doppler signals
were continuously recorded on digital audiotape.
Emboli were counted in each stage of the procedure
without the use of automated emboli detection software.
During the passage of the angiographic contrast medium, a
wide and high increase in Doppler signal intensity that
confused microemboli detection was often observed in theMCA. Therefore, signals that occurred during these phases
of the procedure were excluded from the analysis.
TCD emboli and velocity variables. From our previ-
ous research on TCD monitoring during CAS,8,9 the fol-
lowing TCD emboli variables (isolated and showers) were
thought to be associated with adverse cerebral outcome:
(1) at predilation before stent placement, (2) at stent
deployment, (3) at postdilation after stent placement, and
(4) during introduction and removal of a filter protection
device. Also evaluated for their impact on outcome were
particulate macroembolism, massive air embolism during
balloon rupture, and angioplasty-induced asystole of 15
seconds with significant hypotension (80 mm Hg) in
combination with a 70% reduction in MCA mean blood
flow velocity.
Preoperative patient and procedure related char-
acteristics. Age, sex, preoperative cerebral and retinal
symptoms, and ipsilateral CEA before stent placement were
also documented. Prior research9 showed that use of a filter
wire cerebral emboli protection device resulted in signifi-
cantly more TCD-detected microemboli (isolated as well as
showers) in all three stages (predilation, stent deployment,
and postdilation) of protected procedures compared with
nonprotected procedures. Therefore, the impact of the use
of a filter on cerebral outcome was also evaluated.
Clinical outcome. All patients were formally assessed
before and after the procedure by a neurologist who was
not involved in the intervention. During CAS, a different
neurologist was present in the angiography suite. Patients
held a rubber squeak toy in the contralateral hand and were
instructed to squeeze if symptoms developed.
New cerebral deficits persisting for 24 hours were
regarded as stroke, the severity of which was graded accord-
ing to the modified Rankin scale.12 Major strokes 3 on
the Rankin scale, while minor stroke did not. Procedure-
related deficit was defined per patient and not per proce-
dure. In patients with adverse cerebral outcome, computed
tomography or magnetic resonance imaging of the brain
was performed. In the analyses, we focused on the predic-
tion of transient cerebral deficits (Afx and TIA), minor and
major strokes (ischemic and hemorrhagic), and death 7
days after the procedure.
Statistical analysis. First, the association between ad-
verse cerebral outcome (Afx, TIA, stroke or death) and
each of the previously mentioned TCD variables and pre-
operative patient characteristics was quantified by use of
univariable logistic regression analysis. The odds ratio (OR)
and 95% confidence interval (CI) were used as measures of
association. A variable with a 95% CI that does not include
the value 1 can be considered statistically significantly asso-
ciated with a P  .05. Continuous variables were initially
included without categorization as long as a relation was
plausible, but various cutoff values and transformations
were assessed as well.13
The TCDmicroemboli variables (isolated and showers)
were dichotomized at clinically relevant thresholds on the
basis of previous results8 or marked differences in the actual
incidence of adverse cerebral outcome. Finally, the number
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after stent placement was dichotomized by selecting that
number of showers that showed the highest likelihood ratio
(sensitivity/1 – specificity) in predicting adverse cerebral
outcome.
The calculated probability by logistic regression is used
as a continuous variable, and for each cutoff value of the
TCD variable, the sensitivity and specificity are determined
and graphically depicted as a receiver operating character-
istic (ROC) curve. This is a statistically orientated choice of
the optimal predicting value compared with a choice based
on clinically relevant thresholds.
Our aim was not to develop a prediction model primar-
ily based on preoperative clinical characteristics but to
assess whether and which TCD variables were associated
with adverse cerebral outcome. Accordingly, we estimated
which of the TCD variables was independently associated
with outcome by use of multivariable logistic regression
modelling. The aim of this analysis was the prediction of
adverse cerebral outcome, and so all possible variables
contributing prognostic information should be included in
the model (step-by-step or block-by-block). Therefore, as
is common in prediction research, we defined a useful
association if the OR had a significance level of P .10, and
the nonsignificant (P .10) variables were excluded.
The first model included only the two variables of
dichotomized showers of microemboli at postdilation after
stent placement and angioplasty-induced asystole of 15
seconds with significant hypotension (80 mm Hg) in
combination with a 70% reduction in MCA mean blood
flow velocity. This model was extended with the additional
univariate significant TCD variables (particulate macroem-
bolus and massive air embolism), and it was assessed
whether theOR and 95%CI in this extendedmodel did not
exclude the value 1. Finally, a last model was defined that
was extended with the preoperative patient characteristic
that was significant (P  .10) in the univariable analyses
(preprocedural cerebral ischemia), resulting in the final
model.
For each model, the ability to discriminate between
patients with and without complications was estimated by
using the area under the ROC curve. The ROC area is a
suitable parameter to summarize the predictive or discrim-
inative ability of a model and can range from 0.5 (useless
model, such as a coin flip) to 1.0 (perfect discrimination). A
value 0.7 can be interpreted as reasonable, and a value
0.8 can be interpreted as good. Differences in discrimi-
native value between models were estimated by differences
in ROC area with 95% CI, taking into account the correla-
tion between models because they were based on the same
cases.
RESULTS
Table I lists the distribution of baseline patient charac-
teristics, TCD emboli and velocity variables, and outcome.
Female patients were older than male patients (mean age,
73 vs 69 years, P  .001). Fifty-three patients (9.6%) had
ipsilateral CEA prior to CAS. The composite morbidity andmortality, which includes Afx, retinal infarct, TIA, minor
and major strokes, and death, was 11.5% (63/550). One
patient had a retinal infarct with persistent partial blindness
of the ipsilateral eye, and 36 patients (6.5%) showed tran-
sient retinal (Afx, 6; 1.1%) or cerebral (TIA, 30; 5.4%)
deficits during the procedure or 7 days after. Fifteen
patients (2.7%) had a minor stroke, 6 (1.1%) had a major
stroke, and 5 patients (0.9%) died. The cumulative rate of
minor and major stroke and death was 4.7% (26/550).
In 84 patients (15.8%) with inadequate temporal win-
dows, TCD monitoring of blood flow velocities in the
ipsilateral MCA was not possible. In 15 procedures (2.7%).
no angioplasty or stent placement was performed. The
procedure was discontinued in 11 cases because of techni-
cal or anatomic impediments, in 2 cases because the steno-
sis was less severe than anticipated, and in 1 case because the
ICA had asymptomatically become occluded in the days
between the last preprocedural duplex scan and the proce-
dure. A major stroke occurred in one patient during arte-
riography before CAS. This patient did not receive a stent,
but was included in the present analysis. In three additional
patients (0.5%), poststenting angioplasty was not per-
formed. Of the remaining 448 procedures, 125 (29%)
showed more than five showers of microemboli at postdi-
lation after stent deployment. Particulate macroembolism
and massive air embolism at balloon rupture were noticed
in eight and five procedures, respectively. Finally, angio-
plasty-induced asystole of 15 seconds with significant
hypotension (80 mm Hg) plus 70% reduction in MCA
mean blood flow velocity occurred in 22 procedures (4%).
Showers of microemboli at postdilation showed a signifi-
cant association with adverse cerebral outcome (Table II).
After dichotomization, the TCD emboli variable of more
than five showers of microemboli at postdilation showed a
significant association with adverse cerebral outcome (P 
.003). The three additional TCD variables of particulate
macroembolus, massive air embolism, and severe asystole
with hypotension also showed a statistically significant as-
sociation with outcome. The 95% CIs of these variables
were wide, however. Table II also delineates that the use of
a cerebral emboli filter wire device did not result in a
statistically significantly lower number of adverse cerebral
events (P  .7). Of the patient characteristics, only prepro-
cedural cerebral ischemia was associated with an increased
risk of adverse outcome. Age (whether analyzed as a con-
tinuous or as a dichotomous variable with a cutoff of 75
years), sex, and prior ipsilateral CEA were statistically non-
significant predictors.
The model, including showers of microemboli at post-
dilation and significant asystole and hypotension, is given in
Table III (model 1). The ROC area of this model was 0.64.
After adding the two additional TCD variables (particulate
macroemboli and massive air embolism) to model 1, all
four TCD variables were associated with outcome (model
2, Table III). The ROC area increased to 0.72.
Model 2 was subsequently extended with the only
univariably significant preprocedural patient characteristic
(preprocedural cerebral ischemia). This resulted in a ROC
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variables remained associated with adverse cerebral out-
come. In the present analysis, the use of a filter protection
device did not show a statistically significant association
with cerebral outcome (Table II, P  .7), and, therefore,
this variable was not incorporated in our modeling.
DISCUSSION
In the present study we evaluated which TCD moni-
toring variables were independently associated with early
adverse cerebral outcome and death from CAS. We found
that of all TCD microemboli variables quantified during
the various stages of CAS, only the variable “more than 5
showers of microemboli at postdilation after stent deploy-
ment” was associated with transient and persistent retinal
and cerebral deficits 7 days. This association remained
after taking into account three additional TCD emboli and
Table II. Association of patient characteristics and transcr
Patient characteristics Ou
Age 75 years 3
Male gender 7
Preprocedural cerebral ischemia 6
Prior ipsilateral CEA
Transcranial Doppler emboli and velocity variables
Isolated emboli at prediction 32
Isolated emboli at stent deployment 33
Isolated emboli at postdilation 35
Isolated emboli by use of protection device 31
Showers at predilation 22
Showers at stent deployment 35
No of embolic showers at postdilation:
0-5 51
5 48
Sowers by use of protection device 25
Asystole with hypotension 14
Particulate macroembolus 12
Massive air embolism 8
Use of emboli filtering device 31
CEA, carotid endarterectomy.
Values are absolute numbers (percentages), unless otherwise stated.
*Outcome  patients with periprocedural adverse cerebral events
Table III. Results of multivariable logistic regression anal
Model 1
Determinants
5 showers at postdilation 2.5 (1.3-4.7)




ROC area 0.64 (0.55-0.73
P  .002
ROC, receiver operating characteristic.velocity variables and various patient characteristics. TheTCD emboli variables “macroembolus” and “massive air
embolism” were associated with outcome independent
from the TCD velocity variable (70% reduction of MCA
blood flow velocity during angioplasty-induced asystole
with significant hypotension) and the patient characteristic
“preprocedural cerebral ischemia.”
Our results should be placed in the context with other
reports on TCD monitoring during CAS.14-21 However,
most of these studies described a small number of patients,
often featuring only balloon angioplasty without stent
placement. Moreover, isolated microemboli were not
clearly separated from showers of microemboli, and mac-
roemboli were not differentiated.
The present study is an expansion of a previous research
from our group8 by almost doubling the number of pa-
tients analyzed. In this perspective, it is important to un-
derline that in the former study, the variable “multiple
Doppler variables with outcome
* Outcome OR (95% Cl) P
25.5 1.3 (0.7-2.2) .4
69.6 1.2 (0.7-2.2) .4
30.2 4.6 (2.6-8.1) .0001
10.3 2.3 (0.7-7.6) .3
34.6 0.6 (0.3-1.3) .2
33.5 0.8 (0.4-1.6) .5
33.7 1.5 (0.7-3.6) .3
33.6 0.6 (0.2-2.0) .4
22.4 1.0 (0.6-2.4) .9
34.0 0.8 (0.3-2.4) .8
73.5
26.5 2.7 (1.4-5.0) .003
39.4 0.7 (0.2-3.1) .7
3.7 4.3 (1.7-11.2) .003
0.5 27.8 (5.5-143) .0001
0.2 35.7 (3.9-327) .002
34.3 0.9 (0.5-1.6) .7
OR (95% Cl)
Model 2 Model 3
2.6 (1.3-5.1) 2.6 (1.3-5.3)
6.4 (2.3-17.8) 6.7 (2.1-20.6)
27.0 (4.5-157) 27.4 (4.6-169)
51.4 (5.4-492) 75.7 (7.0-814)
5.0 (2.4-10.4)
0.72 (0.63-0.80) 0.80 (0.73-0.88)



















)showers at postdilation after stent placement” only showed
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adverse cerebral outcome. Although in the present en-
larged study one third (21/63) of the cerebral events
occurred with a symptom-free interval after the procedure,
the variable “more than five showers of microemboli at
postdilation after stent placement” now also showed a
statistically significant association with adverse outcome
7 days.
In addition to clear adverse events such as macroembo-
lism and massive air embolism, microemboli that occur at
postdilation after stent deployment are a major and inde-
pendent risk factor for periprocedural cerebral deficit. Ob-
viously, an uncovered stent squeezes plaque material from
the vessel wall through the stent mesh that subsequently
contributes to embolization in the cerebral circulation.
Various protection strategies have been introduced to
minimize the risk of these embolic events, and in the
present study, a filter wire protection device was used in one
third of the procedures (181/550). However, former re-
search from our institution9 on the impact of filtering
protection devices on the cerebral embolic load showed
that in all three stages of the stenting procedure (predila-
tion, stent deployment, and postdilation), the number of
TCD detected microemboli was significantly higher in
protected than in nonprotected procedures. This resulted
in a changing belief in the usefulness of filter protection
between the two groups involved in CAS: cardiologists
decided to use filters as much as possible; in contrast,
radiologists now use filters as little as possible. In the
present study, however, use of cerebral filter protection
increased from 0% during the first 2 years to 66% during the
last 2 years.
As documented by others,21-23 we also found that
transient, moderate hypotension occurs frequently during
and after CAS and resolves spontaneously in most patients.
Although most of these events can be considered benign
and self-limiting, hemodynamic instability due to asystole
and severe hypotension may complicate CAS. In the
present study, asystole resulted in severe hypotension in 4%
(22/550), with a significant reduction of MCA blood flow
velocities, and this was related with adverse cerebral out-
come in seven of these 22 patients. Most of these cases
occurred during the the first years of our study period.
Undoubtedly, more aggressive use of vasopressor agents,
adequate fluid balance, and advances in technique and
equipment made the procedure safer in the subsequent
years.
It was not our intention to develop a prediction model
primarily based on preoperative clinical and angiographic
predictors of adverse cerebral outcome from CAS. Never-
theless, besides the above-mentioned procedure-related
variables, preprocedural cerebral ischemia was significantly
associated with outcome. Actually, symptomatic patients
were about four times more likely to have an adverse
cerebral outcome (transient and persistent) during CAS
than asymptomatic patients. In CEA, Rothwell et al24,25
showed that in addition to age, female sex, hypertension,
and peripheral vascular disease, preoperative cerebral symp-toms were also a predictor of stroke. Age, gender, and prior
ipsilateral CEA were not associated with cerebral outcome
in the present study on CAS.
To appreciate the present results, a few aspects need to
be discussed. First, in contrast with other studies that
evaluated the association of preprocedural patient charac-
teristics with cerebral outcome from CAS,26 we evaluated
whether clinically relevant intraprocedural TCD emboli
and velocity variables were associated with adverse cerebral
outcome, taking into account some always available basic
patient characteristics.
Second, the analysis includes data from the first years of
CAS; thus, the presence of a learning effect will be likely.
Particularly with respect to hemodynamic instability and
the use of emboli filter wire devices, in the course of time,
interventionists developed an understanding of and reli-
ance on the TCD data.
Third, TCD gives no information about the composi-
tion of the microemboli. Because we excluded from our
analyses the time during which contrast passed through the
MCA during arteriography, almost all of the microemboli
probably were particulate. Significant air embolism was
only noticed after balloon rupture. Moreover, no emboli
detection software was used.
Fourth, although the TCD variables “particulate mac-
roembolus” and “massive air embolism” were indepen-
dently associated with outcome, the 95% CIs of the predic-
tions were wide. In other words, the precision of these
measurements was not high because of the relatively small
number of procedures during which these events hap-
pened.
Fifth, to increase the power of our regressionmodeling,
we used TIA and Afx as clinical end points in addition to
stroke. Probably, these so-called soft end points show
pathophysiologically the same mechanisms as clinically
more important end points such as minor andmajor stroke.
They are therefore useful in a preliminary predictionmodel,
and further research has to prove whether significant cere-
bral embolic load at postdilation also shows a negative
impact on periprocedural stroke.
Finally, because 70% of our patients underwent major
surgery within 3 to 4 weeks after CAS, we limited the
perioperative morbidity and mortality assessment to the
in-hospital (7 days) period. Certainly, the 30-day compli-
cation rates for CAS and for heart or aortic surgery, or both,
will be somewhat higher.
In conclusion, we have determined that in addition to
obviously adverse events such as macroembolism and mas-
sive air embolism, multiple (5) microembolic showers
that occur at balloon deflation during postdilation after
stent deployment, and angioplasty-induced asystole with
hypotension and significant reduction of MCA blood flow
velocities were associated with periprocedural cerebral out-
come. To our knowledge, the association with cerebral
deficits has not been demonstrated before, certainly not by
using amultivariable approach that takes into account some
basic preoperative patient characteristics. We believe this is
relevant information that can be used to guide further
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demonstrate that in CAS, the risk of an adverse cerebral
event is significantly higher in symptomatic than in asymp-
tomatic patients.
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